Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00891774 · ClinicalTrials.gov registry record · NA
Post Market Safety Study and Effectiveness With Evolence in Subjects With Skin Color Types IV-VI
A NA study, sponsored by Johnson & Johnson Consumer and Personal Products Worldwide.
- Completed
- Registry status
- NA
- Development phase
- 172
- Enrollment target
NCT00891774 is a NA study that has completed, run by Johnson & Johnson Consumer and Personal Products Worldwide. The registered enrollment target is 172 participants.
The verdict
NCT00891774, a NA study, has completed, sponsored by Johnson & Johnson Consumer and Personal Products Worldwide.
- COMPLETED
- Registry status
- NA
- Development phase
- 172 participants
- Enrollment target
Study Summary
Approximately 165 subjects with Fitzpatrick Skin Color Types IV, V, and VI and a moderate to deep wrinkle between the corner of the nose and the corner of the mouth, will be treated with EVOLENCE® (an approved collagen filler) to smooth and flatten that wrinkle. They will be observed for 6 months to establish safety of the product as it relates to scarring and changes in skin pigment, and long term effectiveness.
Interventions
- DEVICE EVOLENCE®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2008-12-31 |
| Est. Completion | 2009-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00891774
The ClinicalTrials.gov registry entry for NCT00891774 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 172 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Consumer and Personal Products Worldwide, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EVOLENCE® is the first listed.
NCT00891774 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00891774 about?
NCT00891774 is a clinical study titled "Post Market Safety Study and Effectiveness With Evolence in Subjects With Skin Color Types IV-VI". Approximately 165 subjects with Fitzpatrick Skin Color Types IV, V, and VI and a moderate to deep wrinkle between the corner of the nose and the corner of the mouth, will be treated with EVOLENCE® (an approved collagen filler) to smooth and flatten that wrinkle. They will be observed for 6 months to...
What is the current status of trial NCT00891774?
This trial is currently completed. It is a NA study. The enrollment target is 172 participants. The study started on 2008-12-31. Estimated completion is 2009-11-30.
What interventions are being tested in trial NCT00891774?
The interventions under investigation include: EVOLENCE® (DEVICE).
Who is sponsoring clinical trial NCT00891774?
This trial is sponsored by Johnson & Johnson Consumer and Personal Products Worldwide, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.